.Attributes Medicine, Published online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the empirical SCRUM-Japan GOZILA study, after a median consequence of 11 months, individuals with metastatic stomach lumps who got biomarker-matched treatments based upon circulating cyst DNA profiling showed a more significant professional perk than those acquiring incomparable therapy.